Resource data sheet
DNA Bank Top
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

pCMFlag_hsSMAD2 (#RDB07000)

Expression vector of human SMAD2.

Alternative name SET-0209_1-1
Clone info. Expression vector of human SMAD2. Expression has not yet been confirmed.
Comment Derived from Sugano CAS09876. PCR cloning, forward primer: atgtcgtccatcttgccattcacg; reverse primer: ttatgacatgcttgagcaacgcact. cDNA fragment 293 to 1696nt of NM_005901.5 (cds 293-1696nt) was cloned. Known difference: T to C substitution at 583nt (silent).
Vector backbone pCMV_S-FLAG (RDB05956) (Plasmid)
Size of vector backbone 5.5 kb
Selectable markers Amp^r (E. coli), Neo^r (mammalian cell)
Growth conditions 37C, LB+Amp
Gene/insert name Human MADH2/SMAD2 cDNA
Depositor|Developer DNA Bank, |
 

Distribution information

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms
Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ]
MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ]
MTA, for use for for-profit purpose [Word]
Please visit Information of Request for Distribution.[link] 
Terms and conditions for distribution The RECIPIENT agrees to describe RIKEN BRC as the source of the MATERIAL and cite Gene 200, 149-156, 1997 in any publication.
Additional terms and conditions:
Regrding pRc/CMV:
a) The modified pRc/CMV, and their descendants (collectively, LIFE MATERIALS), should be used for pre-clinical/non-human, research use only.
b) LIFE MATERIALS shall not be used for any commercial purposes.
c) LIFE MATERIALS shall not be transferred beyond the specified recipient.
d) Recipient must contact Thermo Fisher Scientific Inc. at outlicense@thermofisher.com for any desired use of LIFE MATERIALS beyond the scope of a) to c) above.
提供案内 (日本国内) [open/close]

必要書類
提供依頼書  [依頼書の記入例 ]
提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ]
提供同意書 (MTA, 営利目的用)[Word]
手続きの概要は、「提供申込みについて[link]」をご覧ください。
MTAに書く使用条件 発表に際し、理研BRCから入手したことを明記し、指定する文献(Gene, 200, 149-156 (1997))を引用すること。
付加的使用条件:
pRc/CMVについて:
a) The modified pRc/CMV, and their descendants (collectively, LIFE MATERIALS), should be used for pre-clinical/non-human, research use only.
b) LIFE MATERIALS shall not be used for any commercial purposes.
c) LIFE MATERIALS shall not be transferred beyond the specified recipient.
d) Recipient must contact Thermo Fisher Scientific Inc. at outlicense@thermofisher.com for any desired use of LIFE MATERIALS beyond the scope of a) to c) above.

Catalog # Resource name Shipping form Fee
RDB07000 pCMFlag_hsSMAD2 DNA solution JPY 9,460 (not-for-profit academic purpose)
JPY 18,920 (for-profit-research purpose)
plus cost of shipping containers, dry ice (if required) and shipping charge

Please review the QC test results indicated by check icon below as well as clone information before placing your order.

How to cite this biological resource

Materials & Methods section:

The pCMFlag_hsSMAD2 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07000).

Reference section:

Further references such as user reports and related articles (go to bottom)


QC test results

RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by check icon as well as clone information before placing your order.

Test sheet RDB14573_A7B6p1.pdf check

Nucleotide sequence of a portion of this resource (if available).

Primer: CMV-Forward
Sequence file: RDB14573_A7B6a.seq check
>07000_14573_A7B6_CMV-Forward_A11_02_ABI24.ab1
    1 CTGTCACTCC GCCCATTGAC GCAATGGGCG GTAGGCGTGT ACGGTGGGAG GTCTATATAA
   61 GCAGAGCTCT CTGGCTAACT AGAGAACCCA CTGCTTACTG GCTTATCGAA ATTAATACGA
  121 CTCACTATAG GGAGACCCAA GCTGAATTCA CCATGGACTA CAAGGACGAT GACGATAAGG
  181 CGGCCATGTC GTCCATCTTG CCATTCACGC CGCCAGTTGT GAAGAGACTG CTGGGATGGA
  241 AGAAGTCAGC TGGTGGGTCT GGAGGAGCAG GCGGAGGAGA GCAGAATGGG CAGGAAGAAA
  301 AGTGGTGTGA GAAAGCAGTG AAAAGTCTGG TGAAGAAGCT AAAGAAAACA GGACGATTAG
  361 ATGAGCTTGA GAAAGCCATC ACCACTCAAA ACTGTAATAC TAAATGTGTT ACCATACCAA
  421 GCACTTGCTC TGAAATTTGG GGACTGAGTA CACCAAATAC GATAGATCAG TGGGACACAA
  481 CAGGCCTTTA CAGCTTCTCT GAACAAACCA GGTCTCTTGA TGGTCGTCTC CAGGTATCCC
  541 ATCGAAAAGG ATTGCCACAT GTTATATATT GCCGATTATG GCGCTGGCCT GATCTTCACA
  601 GTCATCATGA ACTCAAGGCA ATTGAAAACT GCGAATATGC TTTTAATCTT AAAAAGGATG
  661 AAGTATGTGT AAACCCTTAC CACTATCAGA GAGTTGAGAC ACCAGTTTTG CCTCCAGTAT
  721 TAGTGCCCCG ACACACCGAG ATCCTAACAG AACTTCCGCC TCTGGATGAC TATACTCACT
  781 CCATTCCAGA AAACACTAAC TTCCCAGCAG GAATTGAGCC ACAGAGTAAT TATATTCCAG
  841 AAACGCCACC TCCTGGATAT ATCAGTGAAG ATGGAGAAAC AAGTGACCAA CAGTTGAATC
  901 AAAGTATGGA CACAGGCTCT CCAGCAGAAC TATCTCCTAC TACTCTTTCC CCTGTTAATC
  961 ATAGCTTGGA TTTACAGCCC AGTTTACTTA CTCAGACCTG CATTTTGGTG TTCGATAGCA
 1021 TATTATGATT TAAATCAGAG GTTGGGAGAA ACCTTTCATG CATCACAGCC CTCCACTTCA
1081 CTGTAGATTG CCTTTACGGA CCATTCCAAA ATTCAAGAAG AAAGGATTC
//
Primer: BGH_rev2
Sequence file: RDB14573_A7B6b.seq check
>07000_14573_A7B6_BGH_rev2_B11_05_ABI24.ab1
    1 CGTTTCGCGC TCAGGACGCA CGGGGGAGGG GCAACAACAG ATGGCTGGCA ACTAGAAGGC
   61 ACAGTCGAGG CTGATCAGCG AGCTCTAGCA TTTAGGTGAC ACTATAGAAT AGGGCCCTCT
  121 AGATGCATGC TCGAGCGGCC TTATGACATG CTTGAGCAAC GCACTGAAGG GGATCCCATC
  181 TGAGTTAATA CTTTGTCCAA CCACTGTAGA GGTCCATTCA GATGAAGTTC AATCCAGCAA
  241 GGAGTACTTG TTACCGTCTG CCTTCGGTAT TCTGCTCCCC ACCCTTTCAC AAAACTCATT
  301 CTTATGGTGC ACATTCTAGT TAGCTGATAG ACGGCTTCAA AACCCTGATT AACAGACTGA
  361 GCCAGAAGAG CAGCAAATTC CTGGTTGTTG AAGATCTTCA GATTACAGCC TGGTGGAATT
  421 TTACACACTG TTGCAGGGTG CCAGCCATAT CTCTGATTAC AATTGGGGCT CTGCACAAAG
  481 ATTGCACTAT CACTTAGGCA CTCAGCAAAA ACTTCCCCAC CTATGTAGTA TAAGCGCACT
  541 CCTCTTCCTA TATGCCTTCT TGTCATTTCT ACCGTGGCAT TTCGGTTAAC ATTGGAGAGT
  601 AAACCTAAGC AGAACCTCTC TGAATTTGAT GGGTCTGTAA AGCCATCTAC AGTGAGTGAG
  661 GGCTGTGATG CATGGAAGGT TTCTCCAACC CTCTGATTTA ATTCATAATA TGCTATCGAA
  721 CACCAAAATG CAGGTTCTGA GTAAGTAACT GGCTGTAAAT CCAAGCTATG ATTAACAGGG
  781 GAAAGAGTAG TAGGAGATAG TTCTGCTGGA GAGCCTGTGT CCATACTTTG ATTCAACTGT
  841 TGGTCACTTG TTTCTCCATC TTCACTGATA TATCCAGGAG GTGGCGTTTC TGGAATATAA
  901 TTACTCTGTG GCTCAATTTC CTGCTGGGAA GTTAGTGTTT TTCTGGAATG GGAGTGAGTA
  961 TAGTCATCCA GAGGCCGGAA GTTTCTGTTA GAATCTCCGG TGTGTCGGGG CACTTAATAC
 1021 TGGAGGCAAA ACTTGCTGTC CTCACTCCTC TGATAGTGGG TTAGGGCTTA CGCATACCGT
 1081 TCAATCCCTT TTTTAGGATG AAAGCACATA TCGCCCAGGC TTTTCCAGAG TTGCCTTTGT
1141 GAGG
//
Primer: SV40pro_F_V2
Sequence file: RDB14573_A7B6c.seq check
>07000_14573-A7B6_SV40proF_V2_E04_13_ABI24.ab1
    1 GGACCAAGCT TTTTTGGAGG GCTAGGCTTT TGCAAAAGCT CCCGGGAGCT TGGATATCCA
   61 TTTTCGGATC TGATCAAGAG ACAGGATGAG GATCGTTTCG CATGATTGAA CAAGATGGAT
  121 TGCACGCAGG TTCTCCGGCC GCTTGGGTGG AGAGGCTATT CGGCTATGAC TGGGCACAAC
  181 AGACAATCGG CTGCTCTGAT GCCGCCGTGT TCCGGCTGTC AGCGCAGGGG CGCCCGGTTC
  241 TTTTTGTCAA GACCGACCTG TCCGGTGCCC TGAATGAACT GCAGGACGAG GCAGCGCGGC
  301 TATCGTGGCT GGCCACGACG GGCGTTCCTT GCGCAGCTGT GCTCGACGTT GTCACTGAAG
  361 CGGGAAGGGA CTGGCTGCTA TTGGGCGAAG TGCCGGGGCA GGATCTCCTG TCATCTCACC
  421 TTGCTCCTGC CGAGAAAGTA TCCATCATGG CTGATGCAAT GCGGCGGCTG CATACGCTTG
  481 ATCCGGCTAC CTGCCCATTC GACCACCAAG CGAAACATCG CATCGAGCGA GCACGTACTC
  541 GGATGGAAGC CGGTCTTGTC GATCAGGATG ATCTGGACGA AGAGCATCAG GGGCTCGCGC
  601 CAGCCGAACT GTTCGCCAGG CTCAAGGCGC GCATGCCCGA CGGCGAGGAT CTCGTCGTGA
  661 CCCATGGCGA TGCCTGCTTG CCGAATATCA TGGTGGAAAA TGGCCGCTTT TCTGGATTCA
  721 TCGACTGTGG CCGGCTGGGT GTGGCGGACC GCTATCAGGA CATAGCGTTG GCTACCCGTG
  781 ATATTGCTGA AGAGCTTGGC GGCGAATGGG CTGACCGCTT CCTCGTGCTT TACGGTATCG
  841 CCGCTCCCGA TTCGCAGCGC ATCGCCTTCT ATCGCCTTCT TGACGAGTTC TTCTGAGCGG
  901 GACTCTGGGG GTTCGAAATG ACCGACCCAA GCGACGCCCA ACCCTGCCCA TCACGAGATT
  961 TCGATTCCAC CGCCCGCCTT TCTATGAAAG GTTGGGCTTC GGAATCGTTT TCCGGACGCC
 1021 GGCTGGATGA TCCTCAGCGC GGGATCTCAT GCCTGAGTCC TCGGCCAACC CCAACTGTAA
1081 TGGCAGCTTA ATATGTACAA ATTAAGGCAA TATAAGGC
//

Please visit Sequencing and PCR primers for primer information.


References

Original, user report and related articles